Device Dossier

PROFHILO 3.2% - 32 mg (H-HA) + 32 mg (L-HA)/2 ml - Dermal tissue reconstructive material, microbe-derived

Device Dossier for PROFHILO 3.2% - 32 mg (H-HA) + 32 mg (L-HA)/2 ml - Dermal tissue reconstructive material, microbe-derived (Dermal tissue…

Intended purpose

PROFHILO® is intended for treatment of the malar-zygomatic, sub-malar areas face for contours redefinition and laxity remodeling.

Functional description

PROFHILO® constitutes a buffered physiological solution of high molecular weight and low molecular weight hyaluronic acid (HA) for preventive and corrective aesthetic medicine treatments and counteracting the skin aging process and maintaining appropriate amounts of HA in the dermal layer.

TGA Public Summary